JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

The role of extracorporeal shock wave on plantar fasciitis.

Extracorporeal shock wave therapy for chronic plantar fasciitis has been under investigation since its advent in the early 1990s. Its use has been approved by the U.S. Food and Drug Administration; however, much controversy exists surrounding its mechanism of action, treatment protocols, and clinical efficacy. This article reviews some of the existing theories, opinions, and data in an attempt to summarize the current role that shock wave therapy plays in the treatment of plantar fasciitis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app